Genmab Publishes 2024 Annual Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Truist Securities Reiterates Buy Rating on Genmab A/S (GMAB)
February 13, 2025 7:17 AM ESTTruist Securities analyst Asthika Goonewardene reiterated a Buy rating and $50.00 price target on Genmab A/S (NASDAQ: GMAB).
The analyst comments "We believe investors are anxious to own GMAB ahead of J&J's (JNJ, Not Rated) decision to opt-in on GEN3014, and... More
